During the past decade, Nexus Clinical Research conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 12 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nexus Clinical Research" #1 sponsor was "Galderma R&D" with 7 trials, followed by "Amgen" with 5 trials sponsored, "Innovaderm Research Inc." with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "LEO Pharma" with 3 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nexus Clinical Research" #1 collaborator was "Amgen" with 2 trials as a collaborator, "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Janssen-Ortho LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Nexus Clinical Research" are "Psoriasis" (6 trials), "Psoriatic Arthritis" (6 trials), "Acne Vulgaris" (2 trials), "Arthritis, Rheumatoid" (2 trials) and "Atopic Dermatitis" (2 trials). Many other conditions were trialed in "Nexus Clinical Research" in a lesser frequency.

Most popular intervention types in "Nexus Clinical Research" are "Drug" (19 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Apremilast" (2 trials), "CP-690,550" (2 trials), "Topical Gel Vehicle" (2 trials) and "Abatacept" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nexus Clinical Research" are 24 trials for "All" genders.

Currently, there are NaN active trials in "Nexus Clinical Research". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Nexus Clinical Research, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Nexus Clinical Research, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".